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The endosomal sorting complex required for
transport (ESCRT) complexes are central to re-
ceptor downregulation, lysosome biogenesis,
andbuddingofHIV. TheyeastESCRT-I complex
contains the Vps23, Vps28, and Vps37 proteins,
and its assembly is directed by the C-terminal
steadiness box of Vps23, the N-terminal half of
Vps28, and the C-terminal half of Vps37. The
crystal structures of a Vps23:Vps28 core sub-
complex and the Vps23:Vps28:Vps37 core were
solved at 2.1 and 2.8 A˚ resolution. Each subunit
contains a structurally similar pair of helices that
form the core. The N-terminal domain of Vps28
has a hydrophobic binding site on its surface
that is conformationally dynamic. The C-termi-
nal domain of Vps28 binds the ESCRT-II com-
plex. The structure shows how ESCRT-I is as-
sembled by a compact core from which the
Vps23 UEV domain, the Vps28 C domain, and
other domains project to bind their partners.
INTRODUCTION
Targeted degradation is a fundamental mechanism of pro-
tein regulation and quality control (Hershko et al., 2000;
Hochstrasser, 2000; Pickart, 2001). Many integral mem-
brane proteins are targeted for degradation by their cova-
lent modification with a single moiety of the 76 amino acid
protein ubiquitin (Haglund et al., 2003; Hicke, 2001; Katz-
mann et al., 2002; Raiborg et al., 2003; Sigismund et al.,
2004). Monoubiquitinated membrane proteins are recog-
nized by components of transport machinery with specific
monoubiquitin binding domains and delivered to the lyso-
some for degradation (Haglund et al., 2003; Hicke, 2001;
Katzmann et al., 2002; Raiborg et al., 2003; Sigismund
et al., 2004). Monoubiquitinated transmembrane proteins
en route to the lysosome are sorted throughmultivesicularbodies (MVBs), a subset of late endosomes that contain
vesicles within their interior (Gorden et al., 1978; Haigler
et al., 1979; reviewed by Gruenberg and Stenmark,
2004). Fusion of the limiting membrane of the MVB with
the lysosomal membrane results in delivery of lumenal
MVB vesicles and their contents into the lysosome, where
the vesicles and the transmembrane proteins are de-
graded. Membrane proteins that are excluded from the in-
ner MVB vesicles remain within the limiting membrane of
the MVB. Studies in mammalian cells have revealed criti-
cal roles for MVBs in such seemingly distinct processes
as growth-factor-receptor downregulation (Katzmann
et al., 2002), antigen presentation, developmental signal-
ing, and retroviral budding (Morita and Sundquist, 2004).
Sorting of monoubiquitinated proteins into the MVB
pathway is a highly regulated process and requires the co-
ordinated functions of 17 class E Vps (vacuolar protein
sorting) proteins (Bowers and Stevens, 2005; Katzmann
et al., 2001; Odorizzi et al., 1998). The functional loss of
any individual class E Vps protein results in a malformed
late MVB known as the ‘‘class E compartment.’’ The char-
acterization of these proteins has resulted in the identifica-
tion of three high-molecular-weight cytoplasmic protein
complexes, referred to as ESCRT (endosomal sorting
complex required for transport) complexes I, II, and III
(Babst et al., 2002; Katzmann et al., 2001; reviewed by
Conibear, 2002; Hicke and Dunn, 2003; Katzmann et al.,
2002). The hetero-oligomeric ESCRT complexes are
sequentially recruited to the late endosomal membrane
and drive the formation of MVBs. The ESCRT complexes
and associated proteins have been found to play roles in
retrovirus budding, a process analogous to MVB vesicle
formation with the same topological requirement. A num-
ber of viruses, including human immunodeficiency virus
(HIV), equine infectious anemia virus (EIAV) and Ebola, re-
quire the ESCRTmachinery for budding (Morita and Sund-
quist, 2004).
The ESCRT-I complex directly binds to monoubiquitin
moieties of protein cargo through its UEV (ubiquitin E2 var-
iant) domain of Vps23, a catalytically inactive variant of
a ubiquitin-conjugating enzyme (Katzmann et al., 2001).Cell 125, 113–126, April 7, 2006 ª2006 Elsevier Inc. 113
The UEV domain interacts with not only ubiquitin but also
the P(S/T)XP peptide sequence of the upstream Vps27
complex (Bache et al., 2003; Bilodeau et al., 2003; Katz-
mann et al., 2003) and a number of other cellular proteins,
including the mammalian counterpart of Bro1 (Strack
et al., 2003; von Schwedler et al., 2003) and the ubiquitin
ligase Tal (Amit et al., 2004). P(S/T)XP motifs have been
found in the Gag proteins of many retroviruses such as
HIV-1, HTLV-I, and MPMV (Goila-Gaur et al., 2003; Mar-
tin-Serrano et al., 2003; Pornillos et al., 2003; Scarlata
and Carter, 2003; Strack et al., 2003; von Schwedler
et al., 2003). These viruses use this motif to hijack the
MVB sorting machinery to bud from host cells.
Over the past 3 years, there has been considerable
progress in the structural analysis of the ESCRT com-
plexes (reviewed by Hurley and Emr, 2006). The structures
of the ubiquitin binding UEV domains of yeast (Teo et al.,
2004b) and human (Sundquist et al., 2004) Vps23 have
been determined in complex with ubiquitin, and the struc-
ture of the humanUEV domain was solved in complex with
a peptide containing a retroviral PTAP motif (Pornillos
et al., 2002). The structure of the ubiquitin binding NZF-2
domain of yeast ESCRT-II has also been determined in
complex with ubiquitin (Alam et al., 2004). The structure
of the yeast ESCRT-II core complex has been determined
(Hierro et al., 2004; Teo et al., 2004a).
The structure of the ESCRT-I core, arguably the most
significant remaining piece of the structural puzzle, has re-
mained unsolved. Apart from the UEV domain of Vps23,
the subunits of ESCRT-I do not contain any well-studied
domains. In order to physically map the structure of the
core, we expressed a recombinant form of the yeast
ESCRT-I complex in which the UEV domain was removed
from Vps23, but with all other subunits intact. This com-
plex was subjected to limited proteolysis, the digests
were fractionated by gel filtration, and the resulting frag-
ments were analyzed by protein sequencing and mass
spectrometry. This information was used to identify the
protease-resistant core responsible for the assembly of
the ternary complex. In the process, a core subcomplex
of Vps23 and Vps28 and a Vps28 C-terminal domain
were also identified. The structures of the complexes
were determined, revealing how ESCRT-I assembles.
The Vps28 C-terminal domain was shown to bind to
ESCRT-II in vitro, showing how ESCRT-I and II likely inter-
act. We went on to show that the subunit interfaces iden-
tified in the crystal structure are essential for ESCRT-I as-
sembly and function in vivo in yeast.
RESULTS
Identification of the ESCRT-I Core
This study commenced with the expression and charac-
terization of a recombinant form of the yeast ESCRT-I
complex, referred to here as EIDUEV-A, in which the
UEV domain of Vps23, residues 1–161, was deleted
(Figure 1A). This was the smallest truncation of the intact
complex that could be expressed as a soluble recombi-114 Cell 125, 113–126, April 7, 2006 ª2006 Elsevier Inc.nant complex. EIDUEV-A yielded a predominant peak
with an apparent MW of 190 kDa by gel filtration (Fig-
ure 1B). Sedimentation velocity studies of the EIDUEV-A
complex indicated the presence of two species with cor-
rected sedimentation coefficients of approximately 3.6
and 4.8 S (Figure 1C). A weight-average buoyant molecu-
lar mass of approximately 25 kDa was obtained from a fit
to a single-solute model. This corresponds to a molecular
mass of 98 kDa and is a value just larger than that ex-
pected for the monomeric 1:1:1 ternary complex (Mcalc =
78,057.3 Da), suggesting that the monomeric complex is
the major species. An analysis in terms of two single ideal
solutes yielded improved data fits and indicated that both
monomeric and dimeric states of the ternary complexes
were present. Modeling the equilibrium data to a mono-
mer-dimer mixture yielded excellent fits (Figure 1D) with
a dissociation constant KD of 110–160 mM.
In order to determine whether the ESCRT-I complex
contains a stable core structure, a variant of the EIDUEV
complex with Vps23 truncated to residue 199 and all
Cys mutated to Ala (EIDUEV-B) was expressed and puri-
fied. These modifications were made to reduce a propen-
sity to age-dependent aggregation that was noticed for
the EIDUEV-A construct. EIDUEV-B was subjected to lim-
ited proteolysis with trypsin and endoproteinase Glu-C.
Proteolytic digests of EIDUEV-B were subjected to gel fil-
tration chromatography to separate potential core com-
plexes, subcomplexes, and domains, and the compo-
nents were chemically sequenced (Figure 1E) and in
some cases subjected toMALDI-TOFmass spectrometry.
A binary complex consisting of Vps23(322–385) and
Vps28(8–125) (binary-A) was identified, along with an iso-
lated domain consisting of Vps28(145–242) (Vps28 C
domain). The Vps28 C domain was expressed as a re-
combinant protein, purified, and found to have a native
molecular weight of 14 kDa on gel filtration, as compared
to a calculated molecular weight of 11.6 kDa (data not
shown). We concluded that this fragment of Vps28 was
a monomeric domain that was not part of the core.
The binary-A complex wasmade as a recombinant form
and characterized. For high-resolution crystallographic
analysis, two further truncations of Vps28 were made:
binary-B, with Vps28(13–118), and binary-C, with
Vps28(13–125). Sedimentation equilibrium experiments
on the binary-C (see Figure S1A in the Supplemental
Data available with this article online) and binary-B com-
plexes (Figure S1B) were consistent with monodisperse
single ideal species having molecular masses of 63,900 ±
2,900 and 61,900 ± 600 Da, respectively, showing that
these complexes are stable trimers (Table S1). This finding
is inconsistent with the apparent monomeric 1:1 complex
obtained by crystallography in the presence of the de-
tergent N,N-dimethyldecylamine oxide (DDAO), as de-
scribed below. It was not possible to carry out sedimenta-
tion analysis in the presence of DDAO due to flotation of
the detergent. The most reasonable interpretation is that
the trimer is a nonphysiological artifact due to the expo-
sure of hydrophobic surfaces in the absence of Vps37.
Figure 1. Identification and Characterization of the ESCRT-I Core
(A) Domain structure of ESCRT-I and complexes used in this study.
(B) Gel filtration of the EIDUEV-A construct.
(C) Sedimentation velocity analysis of the190kDapeakobtainedbygel filtrationof theEIDUEV-Aconstruct in (B), showing thepresenceof two species.
(D) Sedimentation equilibrium analysis in terms of a monomer-dimer equilibrium of the EIDUEV-A construct in (B) for data collected at 10 (blue), 12
(green), and 16 (red) krpm. The solid lines show the best-fit global analysis. Best-fit residuals are shown above the plot.Cell 125, 113–126, April 7, 2006 ª2006 Elsevier Inc. 115
Figure 2. Structure of the Vps23:Vps28 Subcomplex
(A) Composite 2Fo  Fc omit map contoured at 1.0 s shown with a portion of the refined model of Vps23.
(B) Ribbon model of the binary complex, Vps23 in orange, Vps28 in blue.
(C and D) The Vps23:Vps28 interfaces, with Vps23 and Vps28 shown as a space-filling surface model, respectively.We suggest that detergent covers these surfaces in the bi-
nary-complex crystal and thereby stabilizes the mono-
meric form.
To determine what portion of Vps37 was involved in the
core complex, the binary-A construct and full-length
Vps37 were coexpressed and purified. This complex
was poorly stable and underwent partial proteolysis dur-
ing purification. The proteolysis products were fraction-
ated on gel filtration and sequenced, revealing cleavage
products beginning at Vps37 residues 130 and 134. The
core and core-A constructs were generated on this basis
(Figure 1A). Another variant, in which Vps23 began at res-
idue 257 (core-B), was designed to determine whether the
predicted coiled coil from residues 257 to 300 contributed
to higher-order oligomerization. Sedimentation equilib-
rium experiments on core (Figure 1F), core-B (Figure S1C),
and core-A (Figure S1D) showed that these species are
monodispersemonomers. The experimentally determined
buoyant molecular masses obtained from single-ideal-116 Cell 125, 113–126, April 7, 2006 ª2006 Elsevier Inc.solute fits (Table S1) are consistent with the presence of
monomeric species having a 1:1:1 stoichiometry of the
Vps28, Vps23, and Vps37 peptides in all of these core-
complex variants.
Structure of the Vps23:Vps28 Subcomplex
The structure of the Vps23:Vps28 subcomplex was deter-
mined by multiwavelength anomalous dispersion (MAD)
from a selenomethionyl derivative of the binary-A complex
at 3.35 A˚ resolution (Table S2). This structure was partially
refined and used as a molecular replacement (MR) search
model to phase crystals of the binary-B complex that dif-
fracted to 2.1 A˚ resolution (Figure 2A). The asymmetric unit
contains two copies of the Vps23:Vps28 heterodimer,
which are related by approximate 2-fold symmetry. The
structure of Vps23 is well defined throughout and consists
almost entirely of two long a helices (Figure 2B and Fig-
ure 3). The Vps28 core contains an extended N-terminal
loop from residue 18 to 30 and five helices, a0–4 (Figure 3).(E) Analysis of a partial endoproteinase Glu-C digest of EIDUEV-B by gel filtration and protein sequencing showing the identification of Vps28 core
boundaries. Additional analyses of Glu-C and tryptic digests were used to determine the core boundaries of Vps23 and Vps37 (not shown).
(F) Sedimentation equilibriumanalysis of the core construct, showing a single species consistentwith a 1:1:1 complex. Datawere collected at 11 (blue),
14 (green), and 17 (red) krpm for loading A280 of 0.50 (left), 0.41 (center), and 0.71 (right). The solid lines show the best-fit global analysis in terms of
a single ideal solute, with the corresponding residuals shown in the panels above the plot.
Figure 3. Structure-Based Sequence Alignment
(A) Vps23 and its homologs. A structural alignment of Vps23 with Vps28 and Vps37 is shown immediately below.
(B) Vps28 and its homologs.
(C) Vps37 and its homologs. Colored circles indicate sites of interaction with other subunits, colored as in Figure 2 and Figure 4. Black triangles in-
dicate mutations with no phenotype either alone or in any combination tested. Black squares indicate mutations with a class E phenotype taken alone
or in combination with others. Black circles under the Vps28 alignment show residues involved in the hydrophobic hole in either the binary or ternary
complexes or both. Pink shading indicates complete conservation; cyan shading indicates >75% conservation.The two helices of Vps23 are antiparallel to each other in
a hairpin arrangement, as are the first two helices of
Vps28. The two pairs of helices are strikingly similar to
each other. Not only are the two pairs of helices aligned
at essentially identical angles to each other, the loop con-
necting the two helices is nearly identical in conformation.
Every one of the 56 Ca carbon atoms in the section
a1-loop a2 in Vps23 can be superimposed on its counter-
part in Vps28 without any breaks, and with an rmsd of just
1.0 A˚.
The two subunits interact extensively over their entire
length, burying a total of 2940 A˚2 of solvent-accessible
surface area from the two proteins (Figures 2C and 2D).
Interactions between the two helical hairpins form thelargest contact surface. The two hairpins are aligned
roughly parallel to each other and rotated about 30º with
respect to each other. Their mutual interactions are cen-
tered at the bend in the hairpins and continue along the
length of Vps28:a1 and Vps23:a2. The Vps23:Phe-371
side chain protrudes deep into a crevice in Vps28, where
it is almost completely buried by interactions with
Vps28:Ile-37, Leu-40, Tyr-44, and Ile-97. The N-terminal
loop of Vps28 threads its way between the ends of the
two Vps23 helices and proceeds to wrap around the C-
terminal part of Vps23:a2. In particular, Vps28:Phe-18
and Val-22 bury themselves in the gap between the N-
and C-terminal ends of Vps23 helices a1 and a2.
Vps28:Leu-24 and Phe-25 form hydrophobic contactsCell 125, 113–126, April 7, 2006 ª2006 Elsevier Inc. 117
with the Vps23:Leu-372 and Trp-375 at the C terminus of
Vps23:a2, and Vps28:Leu-14 interacts with the N-terminal
part of Vps23:a1.
Relatively few polar interactions are observed as com-
pared to the extensive hydrophobic interactions. With re-
spect to the extended N-terminal portion of Vps28, the
side chain of Vps23:Gln-327 makes two hydrogen bonds
to the main chain of Vps28:Val-22, stabilizing its unpart-
nered b conformation. Vps23:His-376 also interacts with
the Val-22 main-chain carbonyl. Vps23:Arg-379 stabilizes
a turn in Vps28 by hydrogen bonding to carbonyls of
Vps28:Pro-23 and Leu-24. Within the main helical inter-
face, Vps23:Arg-364 is a linchpin for a hydrogen bonding
network with Vps28:Asp-42, Gln-77, and Tyr-81.
Themost prominent surface feature of the Vps23:Vps28
subcomplex is found on the back face of Vps28, distal to
Vps23. All four helices of Vps28 together form a loose bun-
dle with a large hydrophobic concavity in the center. The
floor is formed by a1 residues Tyr-44, Val-47, and Ile-48,
and the walls by Phe-78 and Leu-82 of a2, Phe-94 and
Ile-97 of a3, Ile-106 of a a3-a4 loop, and Ile-112 and
Leu-115 of a4. The pocket is largely empty. The tail of
a DDAO molecule is bound near the bottom of the pocket
adjacent to Tyr-44, Ile-97, and Ile-106, although the polar
head group protrudes through an adjacent crevice and not
through the central hole. The Vps23 face distal to Vps28 is
rich in exposed hydrophobic residues. In the crystal, these
faces interact with two ordered detergent molecules,
which form bridges across a noncrystallographic axis of
2-fold symmetry.
Structure of the ESCRT-I Core Complex
The structure of the core complex was determined at 2.8 A˚
resolution by molecular replacement with the Vp23:Vps28
subcomplex (Figure 4A; Table S2). Ternary-complex crys-
tals were grown in the presence of sulfate ions, but in the
absence of detergent. There are two copies of a 1:1:1
Vps23:Vps28:Vps37 complex in the asymmetric unit.
The two 1:1:1 complexes pack tightly against each other,
with the C-terminal a3 and a4 helices of the Vps28 core
packing against each other, against the Vps23 of the op-
posing complex, and with the opposing copy of Vps37
via a bound sulfate ion. The primary Vps23:Vps28 inter-
face in the 1:1:1 complex is identical to that observed in
the binary complex, so there is no ambiguity about which
combination of subunits in the crystal corresponds to the
1:1:1 complex observed in solution.
The structure reveals that the core domain of Vps37
consists of an antiparallel helical hairpin closely similar
to the core domains of Vps23 and Vps28 (Figure 3 and Fig-
ure 4B), again despite a lack of detectable sequence sim-
ilarity. Fifty-five Ca atoms from Vps23 and Vps37 can be
superimposed with an rmsd of 1.1 A˚. The three subunits
are arranged at nearly identical30º angles to each other,
like three cards being held in a hand. Vps23 is the middle
card in the hand, and there is no direct contact between
Vps28 and Vps37. The exposed hydrophobic face of
Vps23 observed in the binary subcomplex is completely118 Cell 125, 113–126, April 7, 2006 ª2006 Elsevier Inc.buried in contacts with Vps37. The Vps23:Vps37 contacts
are extensive, burying 1600 A˚2 of solvent-accessible sur-
face area per subunit.
A series of hydrophobic residues centered on Leu-181,
Phe-184, Ile-185, and Leu-189 of Vps37:a2 form the heart
of the Vps23 binding surface of Vps37. These residues
pack against a hydrophobic surface of Vps23 centered
on a1 residues Leu-345 and Met-348 and a1-a2 loop res-
idue Ile-354. These are the same exposed hydrophobic
residues of Vps23 that were bound to an ordered deter-
gent molecule in the binary complex. Vps23:Asp-340
makes two salt bridges across the interface, with
Vps37:Arg-192 and His-196.
Conformational Changes in Vps28
The a1/a2 core of Vps28 preserves its binary-complex
conformation in the ternary complex, but, beginning at
the N terminus of a3, the remainder of Vps28 undergoes
a dramatic conformational change (Figure 4E). Helix a3
pivots by 20º, and the last turn of the helix unravels in
the ternary complex. Helix a4 occupies an almost com-
pletely different position in the ternary complex, with its
C terminus coinciding with the position observed in the bi-
nary complex. The N terminus of a4 moves by 12 A˚ be-
tween the two complexes, and the helix shifts by 60º about
an axis running through its C terminus. Residues 118–125
are ordered and comprise a C-terminal loop in the ternary
complex. These residues were present in the 3.35 A˚
SeMet crystal of the binary-A complex and were observed
to be disordered in that structure. The C-terminal loop in
the ternary structure occupies the same position in space
that a4 occupies in the binary structure. However, the di-
rection of the chain is reversed such that the C terminus of
the Vps28 core region in the ternary structure coincides
with the N terminus of Vps28 helix a4 in the binary com-
plex.
These large structural changes result in some repacking
of the hydrophobic core of the Vps23:Vps28 portion of the
ternary complex and a restructuring of the exposed hydro-
phobic hole on the distal face of Vps28. The most signifi-
cant change is that Phe-100 points inward into the hydro-
phobic core in the binary complex, where it contacts
Vps23:Ile-377, the aliphatic part of Vps23:Arg-374, and
the ordered internal DDAO molecule. In the ternary com-
plex, Phe-100 points outward and buries itself in the
hydrophobic hole in the second ternary complex of the
asymmetric unit (Figure 4F). In place of the ordered
DDAO molecule that occupies part of the Vps28 hydro-
phobic hole in the binary complex, the Phe-100 of the op-
posing complex fills in the hole, whose size is diminished
in the ternary complex.
Phenotypic Analysis of Interfaces and
Vps28 C Domain in Sorting
To determine which subunit interfaces participate in the
assembly of ESCRT-I and which interactions are required
for function, a series of mutations were engineered that
blocked each of the subunit interfaces. Most interface
Figure 4. Structure of the Vps23:Vps28:Vps37 Core Complex
(A) Density-modifiedmap calculated by the prime-and-switch algorithm and contoured at 0.9 s, overlaid on the refined structure of Vps37, which was
not included in the phase calculation.
(B) Ribbon diagram of the core complex, colored as in Figure 2B and with Vps37 in green.
(C and D) The Vps23:Vps37 interface, with Vps23 and Vps37 shown as a space-filling surface model, respectively.
(E) Conformational change in the Vps28 subunit, with the conformation from the binary subcomplex colored blue and that from the core complex
colored magenta.
(F) The hydrophobic hole in the distal side of the Vps28 subunit, with a crystal-packing-related Vps28:Phe-100 shown in magenta as a marker.
Hydrophobic residues on the surface of Vps28 are colored green.Cell 125, 113–126, April 7, 2006 ª2006 Elsevier Inc. 119
Figure 5. Sorting Defects and Complexes of ESCRT-I Interface Mutants
(A) MVB cargo is visualized using aGFP-CPS fusion, and the limiting membrane of the vacuole is visualized with FM4-64. Shown are Normarski optics
(bottom panels) and fluorescence localization of GFP-CPS (top panels) and FM 4-64 (middle panels) in vps23D cells expressing either wt Vps23, no
Vps23, or Vps23F371D; vps37D cells expressing Vps37L181R,I185R; and vps28D cells expressing Vps28L40D,Y44D or Vps28D145–242.
(B) Mutations at the molecular interface of ESCRT-I disrupt complex assembly in vivo as determined by gel filtration chromatography. Elution of mo-
lecular weight standards are indicated on the top and at the bottom. The column fractions were analyzed byWestern blot using antibodies specific for
Vps23, HA, and Flag epitopes.mutants had normal phenotypes such as Vps23:A367P
(Table S3), which was designed to destabilize Vps23 helix
a2. Some of the mutants with normal phenotypes were120 Cell 125, 113–126, April 7, 2006 ª2006 Elsevier Inc.tested for their ability to form normal complexes in vivo,
and A367P (Figure 5B) and all suchmutants tested formed
intact complexes (Table S3). We were able to engineer at
Figure 6. Structural and Functional Organization of ESCRT-I
(A) The Vps28 C domain binds to full-length ESCRT-II complex as determined by a pull-down assay. Lanes on the SDS-PAGE gel are labeled at top.
Molecular weights at left are in kDa.Cell 125, 113–126, April 7, 2006 ª2006 Elsevier Inc. 121
least onemutant form of each participating subunit in each
interface that disrupted the complex and led to an abnor-
mal phenotype. To probe the Vps23:Vps28 interaction, the
Vps23:F371D mutation was engineered to disrupt hydro-
phobic interactions between Vps23 and Leu-40, Tyr-44
of Vps28. Vps23:F371D has a class E phenotype (Fig-
ure 5A) and forms a 1:1 Vps23:Vps37 subcomplex (Fig-
ure 5B). The Vps28:L40D/Y44D double mutant disrupts
the same hydrophobic cluster at Vps23:F371D. This mu-
tant has a class E phenotype and forms a presumed
Vps28 monomer (not detected by S300 gel filtration) and
a 1:1 Vps23:Vps37 subcomplex (Figure 5B). The size re-
duction of Vps23-containing complex in both mutant cells
is similar to that observed in vps28D strains (Babst et al.,
2000).
To analyze interaction between Vps23 and Vps37, mu-
tations were made in Vps23 and in the binding sites for
Vps23 on Vps37. The Vps23:L345D/M348D double mu-
tant disrupts hydrophobic interactions between Vps23
and Leu-181, Ile-185 of Vps37. Both Vps23:L345D and
L345D/M348D have a class E phenotype and form a 1:1
Vps23:Vps28 subcomplex. The Vps37:L181R/I185R dou-
ble mutant disrupts the same hydrophobic interactions at
Leu-345 and Met-348 of Vps23, leading to a class E phe-
notype and formation of a presumed Vps37monomer (not
detected by S300 gel filtration) and 1:1 Vps23:Vps28 sub-
complexes. The size reduction of Vps23-containing com-
plex is similar to that observed in vps37D strains (Katz-
mann et al., 2001). The behavior of these mutants shows
that the Vps23:Vps28 and Vps23:Vps37 interfaces can
be disrupted by mutations, that subcomplexes can exist
in vivo when a given interface is disrupted, and that such
subcomplexes are not functional in vivo. We find a one-
to-one correspondence between those interface mutants
that disrupt physical formation of the complex and those
that yield a class E phenotype.
As described below, we identified the Vps28 C domain
as the locus for binding to the ESCRT-II complex. Deletion
of the Vps28 C domain leads to a strong class E pheno-
type (Figure 5A), consistent with an essential function for
this domain. However, the ESCRT-I complex still assem-
bles normally in vivo (Figure 5B). In contrast to the interfa-
cial mutants described above, the block in function is not
due to disruption of complex formation. Rather, it is con-
sistent with the loss of an essential interaction with a part-
ner external to the ESCRT-I complex.
Protein:Protein Interactions
In order to determine which part of the ESCRT-I complex
binds to the ESCRT-II complex, His6-tagged ESCRT-I
core and Vps28 C domain were immobilized on Co-Talon
resin and assessed for the ability to bind the intact re-
combinant ESCRT-II complex. The Vps28 C domain
bound to the intact ESCRT-II complex. However, no inter-122 Cell 125, 113–126, April 7, 2006 ª2006 Elsevier Inc.action was observed with the ESCRT-I core, with the
ESCRT-II core complex (Vps22:Vps25:Vps36 D1–393),
or with a putative domain in Vps36 comprising residues
289–385 (Figure 6A). This suggests that the Vps28 C
domain is the major locus for ESCRT-II binding by the
ESCRT-I complex and that Vps28 C domain binding to
ESCRT-II requires Vps36 residues 1–288. This region of
Vps36 consists largely of a GLUE domain into which two
NZF domains are inserted. The GLUE domain is con-
served in human Vps36 (Slagsvold et al., 2005), but the
NZF domains are not, so it seems likely that the Vps28 C
domain binds to the Vps36 GLUE domain.
DISCUSSION
Structural analysis of the ESCRT-I complex allows us to
understand the assembly and organization of this key traf-
ficking complex (Figure 6B). The core complex is a 1:1:1
heterotrimer. The UEV domain of Vps23 is monomeric in
isolation and bound to ubiquitin and PTAP motif peptides
(Pornillos et al., 2002; Sundquist et al., 2004; Teo et al.,
2004b), and it is unlikely to influence the oligomerization
of the 1:1:1 heterotrimer. The fundamental unit of the
full-length Vps23:Vps28:Vps37 complex is therefore a het-
erotrimer of 1:1:1 stoichiometry. The core of Vps23 identi-
fied here coincides with the region of human Vps23 iden-
tified as a steadiness box required for the stability of
human ESCRT-I (Feng et al., 2000) and that interacts
with human Vps28 (von Schwedler et al., 2003). Our find-
ing that the C terminus of Vps37 is part of the core agrees
with the finding the corresponding part of the ‘‘ModR’’ mo-
tif of human Vps37A is critical for association with the rest
of the human ESCRT-I complex (Bache et al., 2004).
The EIDUEV-A core complex, the construct closest to
intact ESCRT-I that we were able to characterize in re-
combinant form, has a lower native molecular weight
than the naturally occurring ESCRT-I complex purified
from yeast (Katzmann et al., 2001), which has a native mo-
lecular weight estimated in the 350 kDa range on the basis
of gel filtration chromatography of complexes obtained
from yeast. The UEV domain alone only accounts for
18.1 kDa per Vps23 subunit. The EIDUEV-A complex
shows a mixture of interconverting monomer and dimer
species, while all other ternary complexes examined by
sedimentation analysis were monomeric. Gel filtration re-
sults for EIDUEV overstate the true native molecular
weight, and the same could be true for the intact
ESCRT-I complex. There is a time-dependent increase
in the aggregation of this material. These factors may ac-
count in part for the difference between these results and
the previous estimate of 350 kDa (Katzmann et al., 2001).
We cannot exclude that there are factors that have yet to
be identified that can promote oligomerization of the fun-
damental 1:1:1 unit in vivo.(B) Structures are shown for the UEV domain of human Vps23 in complex with ubiquitinated pro-CPS (red) (Sundquist et al., 2004) and the HIV-1 p6
PTAP-containing peptide (magenta) (Pornillos et al., 2002). The human domain is shown because the complexes with the PTAP peptide and ubiquitin
are both available. The predicted coiled-coil domain in the central part of Vps23 is omitted for simplicity.
We found that ESCRT-I consists of a tightly associated
core comprising one-third of the mass of the complex,
with the remainder consisting of additional domains and
their linkers projecting from the central core (Figure 6B).
This type of hub-and-spokes organization is now familiar
in trafficking complexes. The best characterized of such
complexes are the AP clathrin adaptor complexes. AP-1
and 2 consist of a core comprising just over two-thirds
of the mass of the entire complex and two large append-
age domains linked to the core by long flexible linkers
(Collins et al., 2002; Heldwein et al., 2004). The yeast
ESCRT-II complex consists of a core comprising some
two-thirds of the mass of the complex, with a series of ad-
ditional domains linked to the N terminus of the core por-
tion of one subunit, Vps36 (Hierro et al., 2004; Teo et al.,
2004a). The ESCRT-I complex is distinguished from com-
plexes such as AP-2 and ESCRT-II in that, relative to the
total mass, the portion devoted to the core is about half
of that found in these other complexes. However, the
same basic core-and-appendages formula applies to all
of these systems.
The three subunits of ESCRT-I have no detectable pri-
mary sequence similarity to each other, yet they associate
with each other through two-helix core domains that are
strikingly similar. This recapitulates a similar observation
in ESCRT-II in which all three subunits of that complex, de-
spite a complete lack of detectable sequence similarity, all
contain core tandem winged-helix domains (Hierro et al.,
2004; Teo et al., 2004a). Pseudosymmetric internal re-
peats are often seen in structures of single polypeptide
chains. In such proteins, it is usually speculated that these
protein structures arose by the concatenation of dupli-
cated genes, followed by their divergence over time. It is
tempting to speculate that the multiple subunits of the
ESCRT-I and II complexes might have evolved from
a common ancestor, one each for ESCRT-I and II.
Much of the interest in the ESCRT pathway derives from
its role in the budding of HIV and other retroviruses. Most
of the residues involved in subunit interfaces in the yeast
complex are conserved in the human orthologs of
ESCRT-I subunits. All but 2 of the 11 residues that are
found in the hydrophobic hole on the surface of ESCRT-I
are highly conserved from yeast to human (Figure 3 and
Figure 4F). This suggests that the human ESCRT-I com-
plex will have a similar fundamental architecture and will
possess a similar hydrophobic hole on its surface. Al-
though we do not know the function of the hydrophobic
hole, its conservation suggests that it will have some func-
tional importance. Amajor goal of research into the human
ESCRT-I complex is to develop anti-HIV therapeutics tar-
geted at this complex, as the human ESCRT-I complex
has been shown to be essential for HIV budding (Demirov
et al., 2002; Eastman et al., 2005; Garrus et al., 2001;
Goila-Gaur et al., 2003; Martin-Serrano et al., 2001,
2003; Scarlata and Carter, 2003; Strack et al., 2003; Stu-
chell et al., 2004; VerPlank et al., 2001; von Schwedler
et al., 2003; as reviewed by Freed, 2003; Morita and Sund-
quist, 2004). It is unlikely that a small-molecule inhibitorcould be developed to disrupt the assembly of the com-
plex through competition with subunit interfaces since
these surfaces are so large. On the other hand, the hydro-
phobic hole presents a more attractive target. We have al-
ready found that it can bind an ordered detergent mole-
cule and that it can undergo conformational changes. A
number of effective inhibitors of protein:protein com-
plexes act not by blocking interfaces but rather by block-
ing conformational cycling by stabilizing and trapping one
conformation out of all the steps in a conformational cycle
(Pommier and Cherfils, 2005). While we are unsure of
whether the conformational change occurs as part of
a physiological regulatory mechanism or not, the observa-
tion that Vps28 is capable of such a structural change is
encouraging for the development of small-molecule
ESCRT-I blockers.
Taken together, the structural and functional results
presented here provide a picture of the organization of
the ESCRT-I complex. We found that the fundamental
unit of the ESCRT-I complex is a 1:1:1 heterotrimer, which
appears to be capable of forming weakly interacting di-
mers in vitro and higher-order oligomers in vivo. The com-
plex is held together by a compact core that comprises
only a third of the mass of the complex. From this core,
several domains project to bind a variety of partners.
The Vps23 UEV domain, which is responsible for binding
ubiquitinated cargo and the Vps27 upstream complex, is
connected to the core by 160 residues, some predicted
to be in flexible linkers and others to form a coiled-coil do-
main. The Vps28 C domain, which is responsible for bind-
ing ESCRT-II, in contrast, is connected by a linker of less
than 20 residues. The Vps28 C domain is intimately
connected to the conformationally labile portion of the
Vps28 core domain. It will be important to investigate
whether ESCRT-II binding could regulate a conformational
change in the ESCRT-I core and to identify binding part-
ners for the Vps37 N domain and Vps23 central coiled-
coil domain. The structural model presented here provides
the framework needed for a complete understanding of
the functional organization of ESCRT-I.
EXPERIMENTAL PROCEDURES
Expression Vectors
DNAs coding for the appropriate regions of yeast Vps23, Vps28, and
Vps37 (Figure 1A) were amplified by PCR to generate cassettes con-
taining the Shine-Delgarno translational start signal (Hierro et al.,
2005) and cloned directly into the polycistronic pST39 vector (Tan,
2001).
Limited Proteolysis, N-Terminal Amino Acid Sequencing,
and Mass Spectrometry
The EIDUEV-B complex was digested with varying concentrations of
trypsin or endoproteinase Glu-C at 4ºC overnight. The digested protein
samples were separated on SDS-polyacrylamide gel, transferred to
polyvinylidene fluoride membrane, and stained with SimplyBlue Safe-
Stain (Invitrogen). Bands were excised and subjected to N-terminal
amino acid sequencing using a 492cLC protein sequencer (Applied Bi-
osystems). Limited proteolysis was also combined with gel filtration to
isolate and identify core subcomplexes of ESCRT-I. ProteolyzedCell 125, 113–126, April 7, 2006 ª2006 Elsevier Inc. 123
samples of EIDUEV-Bwere fractionated bypassing themover a Super-
dex 200 column (Pharmacia). Resulting gel filtration fractions were fur-
ther separated by SDS-PAGE and subsequently sequenced. In some
cases, mass spectrometry (MALDI-TOF) analysis was utilized to con-
firm the identity of the proteins in the associated subcomplexes.
MALDI-TOF samples were prepared by mixing 1 ml of protein sample
in 49 ml of matrix buffer (0.07% trifluoroacetic acid and 33% acetoni-
trile). A matrix solution was prepared by mixing excess sinapinic acid
with 30 ml of matrix buffer. One microliter of both sample solution
and matrix solution were spotted on a gold plate and were dried at
room temperature. The plated samples were then analyzed on a Voy-
ager-DE MALDI-TOF mass spectrometer (Applied Biosystems).
Crystallization and Data Collection
Crystals of the binary-A and B subcomplexes were grown at 4ºC by
hanging-drop vapor diffusion bymixing 2 ml of 5 mg/ml protein solution
(40 mM Tris [pH 7.4], 120 mM NaCl, 0.02 M DDAO) with 13% PEG
3350, 200 mMMgCl2, and 20% glycerol. Crystals were looped directly
from the crystal drop and flash frozen in liquid nitrogen in preparation
for low-temperature data collection. Se edgeMAD data were collected
from the binary-A crystals at Stanford Synchrotron Radiation Labora-
tory beamline 9-2, and data were indexed and reduced using
MOSFLM and SCALA (CCP4, 1994). Native data on the binary-B crys-
tals were collected at Advanced Photon Source beamline SER-CAT
22-ID and processed using HKL2000 (HKL Research).
Crystals of the core complex were grown at 25ºC by hanging-drop
vapor diffusion by mixing 2 ml of 6 mg/ml protein solution with equal
volume mother liquor (100 mM trisodium citrate [pH 5.6], 900 mM lith-
ium sulfate, and 500 mM ammonium sulfate). Streak seeding per-
formed after 1 day of equilibration was carried out to obtain diffrac-
tion-quality single crystals, which appeared in 1–2 days. Crystals
were cryoprotected in mother liquor supplemented with 25% glycerol
and flash frozen in liquid nitrogen. Data were collected at APS beam-
line 22-ID and indexed and reduced using HKL2000 (HKL Research).
Structure Determination
Phases were calculated for binary-A from a two-wavelength (Gonzalez
et al., 1999) Se-MAD data set to 3.35 A˚ using SOLVE (Terwilliger and
Berendzen, 1999). Two selenium sites were located, and the resulting
electron density map was improved using density modification in
RESOLVE (Terwilliger, 2000). The map was traced using the modeling
program O and refined using CNS (Brunger et al., 1998). The structure
of the binary-B subcomplex was solved by molecular replacement us-
ing MOLREP (Vagin and Teplyakov, 1997), using binary-A as a search
model. Two copies of the complex were found, resulting in an R factor
of 44.8% and a correlation coefficient of 55.8%. The model was im-
proved by cycles of manual building in O and was refined using CNS
and REFMACwith TLS parameter refinement (Murshudov et al., 1997).
The structure of the ESCRT-I core complex was determined by mo-
lecular replacement using MOLREP with binary-A as a search model.
Two solutions were found, resulting in an R factor of 53.3% and corre-
lation coefficient of 33.6%. Subsequent refinement in CNS dropped
the R factor and free R factor to 41.2% and 46.8%, respectively. The
resulting electron density maps were improved by prime-and-switch
phasing (Terwilliger, 2004) using RESOLVE. The prime-and-switch
electron density map was sufficient to manually build two copies of
the structure of Vps37 absent from the search model as well as to re-
veal substantial reconfiguration of the C terminus of Vps28. Manual
building for this structure was completed utilizing O (Jones et al.,
1991), and CNS was used in refinement of the structure.
Microscopy
Living cells expressing the GFP-CPS chimera were harvested at an
A600 of 0.4–0.6, labeled with FM4-64 for vacuolar membrane staining,
and resuspended inmedium for visualization. Visualization of cells was
performed on a fluorescence microscope (Axiovert S1002TV; Carl
Zeiss MicroImaging, Inc.) equipped with fluorescein isothiocyanate124 Cell 125, 113–126, April 7, 2006 ª2006 Elsevier Inc.(FITC) and rhodamine filters, captured with a digital camera (Photome-
trix), and deconvolved using DeltaVision software (Applied Precision
Inc.). Results presented were based on observations of >120 cells.
Gel Filtration Analysis of Yeast Complexes
For gel filtration analysis, yeast cells were spheroplasted and lysed in
PBS containing 0.1 mM AEBSF, 1 mg/ml pepstatin A, 1 mg/ml leupep-
tin, 1 mM benzamide, and protease inhibitor cocktail (Complete;
Roche Molecular Biochemicals). The lysate was precleared for 5 min
at 300  g followed by a 100,000  g centrifugation for 1 hr at 4ºC.
The following lysate was loaded onto a Sephacryl S300 column (16/
60; Amersham Life Sciences) and separated with PBS. Fractions
were analyzed with Western blotting using anti-HA and anti-Flag
monoclonal antibodies and anti-Vps23 polyclonal antibody.
Pull-down Assay
Samples of the ESCRT-I core, full-length, and Vps36D1–393 ESCRT-II
complexes; the Vps36 289–385 fragment; and bovine serum albumin
(BSA) were mixed at a molar ratio of 3:1 with His6-Vps28-C in 200 ml
of binding buffer (50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 5 mM
b-ME). After 1 hr incubation at room temperature, 50 ml of Co-Talon
resin pre-equilibrated with the binding buffer was added, and the mix-
ture was incubated for 2 hr. The resin was washed three times with 200
volumes of binding buffer plus 5 mM imidazole to remove unbound
material. The bound proteins were eluted by boiling in sample buffer
and were visualized in SDS 12% polyacrylamide gel electrophoresis
using Coomassie blue staining.
Supplemental Data
Supplemental Data include three tables and one figure and can be
found with this article online at http://www.cell.com/cgi/content/full/
125/1/113/DC1/.
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Accession Numbers
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tively.
Note Added in Proof
The structure of the yeast ESCRT-I core was also independently deter-
mined by Teo et al. (2006) in this issue of Cell (99–111).
